Vaccine and Infectious Disease Division

Clinical Sciences

The clinical sciences-based faculty focuses primarily on employing clinical trials for the advancement of understanding infectious diseases. Pathogens of interest include viruses (e.g., HIV, HSV-2, HHV8, and CMV), fungal pathogens such as Aspergillus spp. and the Mucorales and infection-related cancers. These studies focus primarily on diagnostic, therapeutic, and preventive measures, and collaborations between clinical scientists and basic researchers provide a unique and invaluable opportunity to utilize patient specimen repositories and data in biomedical research.

Faculty

Staff Scientist, McElrath Lab, Vaccine and Infectious Disease Division
Research interests include early innate immune responses to HIV vaccines on subsequent adaptive immune responses and systems biology analyses of how immune responses are shaped
Head, Infectious Disease Sciences Program, VIDD Research Interests
Professor, Medicine, University of Washington
Attending Physician, SCCA Infectious Disease Consulting Service, Seattle Cancer Care Alliance
Infections in the immunocompromised host, especially diagnosis, prevention and treatment of CMV, VZV, BK virus, adenovirus, and respiratory virus infections. Research includes understanding the genetic basis of infeciton complications, genome and gene expression studies.
Phone: (206) 667-4898
Fax: (206) 667-4411
Director, UCI/Hutchinson Center Cancer Alliance, Fred Hutchinson Cancer Research Center
Epidemiology, natural history, and treatment of human herpesvirus 8 infection and treatment of Epstein Barr Virus-associated lymphomas. HIV-related cance and infections as a complication of cancer care. Cancer epidemiology, pathobiology, treatment and training in resource-limited settings.
Phone: (206) 667-4600
Fax: (206) 667-1965
Research Associate Professor, Laboratory Medicine, University of Washington
Graduate Faculty, Laboratory Medicine, University of Washington
Director, Center for AIDS Research Immunology Core, University of Washington
Characterizing T cells induced by candidate vaccines using flow cytometry. Developing new assays to evaluate vaccine efficacy with HIV Vaccine Trials Network. Studies include examining T cell function at the single-cell level using advanced flow cytometric techniques; examples include T cell responses to vaccination and to viral infections such as CMV, EBV, HIV, and hepatitis B.
Director for Scientific Affairs, HIV Vaccine Trials Network
Affiliate Professor, Epidemiology and Global Health, University of Washington
The conduct of HIV vaccine trials, novel vaccine strategies, the conduct of clinical trials in resource-poor settings, and factors that help prevent sexual transmission of HIV.
Phone: (206) 667-7938
Fax: (206) 667-7711
Professor, Medicine, University of Washington
Adjunct Associate Professor, Microbiology, University of Washington
Director, Infectious Diseases Fellowship Training Program, University of Washington
Determining how changes in microbial communities impact human health; identifying, characterizing, and culturing microbes found in the human genital tract; and associating the reproductive tract microbiome with human disease. Developing molecular diagnostic tests to detect and identify pathogens in immunocompromised hosts such as cancer patients.
Phone: (206) 667-1935
Fax: (206) 667-4411
Affiliate Associate Professor, Statistics, University of Washington
Developing methods and tools for high throughput, high dimensional experiments with applications in vaccine research and immunology; flow cytometry, peptide microarrays, next generation sequencing; Bayesian inference and computation and statistical computing
Phone: (206) 667-4076
Fax: (206) 667-4378
Clinical Trials Physician /Protocol Team Leader, HIV Vaccine Trials Network (HVTN)
Immunology and vaccine design for development of vaccines, especially HIV-1 vaccine
Associate Director for Laboratory Operations, HIV Vaccine Trials Network (HVTN)
Immunologic endpoint determination for experimental vaccines (HIV, pneumococcus, malaria, TB, flu) and Logistics, operations, quality assurance, and assay validation for immunologic evaluation of vaccines in the clinical trial setting
Director of Clinical Development, HIV Vaccine Trials Network (HVTN)
Clinical Trials Physician/Protocol Team Leader, HIV Vaccine Trials Network (HVTN)
HIV vaccine development and trial design, combination HIV prevention, mucosal immunology and mucosal sampling design in HIV prevention trials, the intersection of oncology and infectious disease, comparative effectiveness, decision analysis and health-related quality of life
Senior Vice President and Director, Vaccine and Infectious Disease Division
Professor of Medicine, University of Washington
Adjunct Professor, Pathobiology, Global Health, and Laboratory Medicine, University of Washington
Research centers on developing an HIV vaccine and investigating the complex relationship between HIV and the immune system and the influence of antiretroviral therapy.
Professor, Laboratory Medicine, University of Washington
Graduate Faculty, Laboratory Medicine, University of Washington
Laboratory diagnosis of viral disease in humans. Natural history and epidemiology of genital herpes and neonatal herpes.
Fax: (206) 667-6366
Professor, Medicine, Laboratory Medicine, and Epidemiology, University of Washington
Graduate Faculty, Medicine, Laboratory Medicine, and Epidemiology, University of Washington
Attending Physician, SCCA Infectious Disease Consulting Service, Seattle Cancer Care Alliance
Epidemiology, natural history, therapy, and prevention of HSV and other herpesvirus infections; interactions between HSV and HIV Vaccines and clinical trials
Phone: (206) 520-4340